Knight Therapeutics (OTCMKTS:KHTRF) Stock Price Crosses Below Fifty Day Moving Average of $4.19

Knight Therapeutics Inc. (OTCMKTS:KHTRF)’s share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $4.19 and traded as low as $4.13. Knight Therapeutics shares last traded at $4.13, with a volume of 100 shares changing hands.

Knight Therapeutics Stock Performance

The firm has a 50 day simple moving average of $4.19 and a two-hundred day simple moving average of $4.14.

Knight Therapeutics Company Profile

Knight Therapeutics Inc develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma.